Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good call on EOD volume and it preceding price.
He received treatment at M.D Anderson (Texas) from doctors involved in the Direct trial. But they also grow grapefruit in Texas. Personally I’m fond of the Texas Ruby Red’s…..
Agreed. That’s the big picture perspective that needs to play out for the benefit of many (beyond L) and future immunotherapy’s in general.
You’re eloquently summed up some thoughts (and added more) rattling around the back of my head here in the wee hours.
On a side note I recall us on a back n’ forth a few years ago in agreement on the our desire to get Direct going in the pipeline. I’ve modified my thinking somewhat since and see importance of bringing L through to a final fruition…..finally….. Long strange trip.
I’ve been thinking TLD would come in the context you lined out. Hence my reply to your Sawston certification update post would be “cool” news to get PR’d.
Sawston update would be cool especially if certification is “on course”.
Thanks, for your added in country perspective on MHRA.
Cool. Does make one wonder how long the WHO re-classification was in the works? And noting the re-classification does not make a lot of difference for the L trial. With all things being equal probably best the journal publication is subsequent WHO re-classification……Not to imply anything beyond random thinking of the late night variety.
The long tail (pun intended)……cool story.
If I was a betting man (I’m invested in NWBO make your own call…as I know you will) I would bet Ms Lappin peruses this board.
Gary, good and valid points. The G7 reached agreement this month on global minimum tax which should “tap the breaks” on offshoring. Domestically a flat tax would/could be an easy an equatable solution, but I don’t see any solution coming anytime soon……paraphrasing Churchill “You can count on America to do the right thing……. after exhausting all other options.” …….. I expect we still have some more options (not stock) to exhaust.*
*Said the man who made 2nd prepayment on 2021 estimated taxes this week….only two more to go.
Agreed! I picture Les as being from the Cobal or Fortran era.....or a wee bit (no pun intended) before. Need some keypunch chaff in his hair if he does the show.
Very obvious very cool.
Yes, and still cool..
Cool, thanks
Good and valid points. Best wishes.
Cool, thanks.
Cool, thanks.
That’s all part of being human.
Decent call....
Cool, thanks.
Cool......and as an investor a possibly intriguing tidbit in this change of course. For the cancer patients I hope there is good reason (significant “sea change” developments) for them to be in attendance.
“No fear” is noted.
Um....good call.
Cool......very cool, thanks.
“Houston” and “rocket fuel” hypergolic potential......
Thanks, for the the real world perspective....it’s where we all live.
Well there is Covid....(in the interest of providing an “out”....albeit more than one vaccine exists)
Law of averages would amount to a number albeit small......at this point in the NWBO time continuum
That’s good stuff....from a humor perspective too.
Facts can be hilarious.
Cool......But why would she still be pursuing this???
I would agree a MRK and/or BMY could optimize broader delivery to patients.
Interesting wording for the session title which I’m certain is noted by others......
Yeah, I’d not bet “the over”...
Cool.......possibility of synergy really cool.
Gary, agree. Scaling was a concern (and also a challenge I’d like to see) and CRL alleviates this concern....let’s see.